Epigenetic silencing and activation of transcription: influence on the radiation sensitivity of glioma cell lines

References

• Alimova I, Birks DK, Harris PS, Knipstein JA, Venkataraman S, Marquez VE, Foreman NK, Vibhakar R, 2013. Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells. Neuro-oncology. 15:149–160.
   PubMed Web of Science ®Google Scholar
• Alimova I, Venkataraman S, Harris P, Marquez VE, Northcott PA, Dubuc A, Taylor MD, Foreman NK, Vibhakar R, 2012. Targeting the enhancer of zeste homologue 2 in medulloblastoma. Int J Cancer. 131:1800–1809.
   PubMed Web of Science ®Google Scholar
• Allalunis-Turner J, Barron GM, Day RS 3rd. 1997. Intact G2-phase checkpoint in cells of a human cell line lacking DNA-dependent protein kinase activity. Radiat Res. 147:284–287.
   PubMed Web of Science ®Google Scholar
• Bachmann IM, Halvorsen OJ, Collett K, Stefansson IM, Straume O, Haukaas SA, Salvesen HB, Otte AP, Akslen LA. 2006. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol. 24:268–273.
   PubMed Web of Science ®Google Scholar
• Boros J, Arnoult N, Stroobant V, Collet JF, Decottignies A. 2014. Polycomb repressive complex 2 and H3K27me3 cooperate with H3K9 methylation to maintain heterochromatin protein 1α at chromatin. Mol Cell Biol. 34:3662–3674.
   PubMed Web of Science ®Google Scholar
• Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. 2003. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22:5323–5335.
   PubMed Web of Science ®Google Scholar
• Campbell S, Ismail IH, Young LC, Poirier GG, Hendzel MJ. 2013. Polycomb repressive complex 2 contributes to DNA double-strand break repair. Cell Cycle. 12:2675–2683.
   PubMed Web of Science ®Google Scholar
• Clarke J, Penas C, Pastori C, Komotar RJ, Bregy A, Shah AH, Wahlestedt C, Ayad NG. 2013. Epigenetic pathways and glioblastoma treatment. Epigenetics. 8:785–795.
   PubMed Web of Science ®Google Scholar
• Cook PJ, Ju BG, Telese F, Wang X, Glass CK, Rosenfeld MG. 2009. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature. 458:591–596.
   PubMed Web of Science ®Google Scholar
• Cowell IG, Sunter NJ, Singh PB, Austin CA, Durkacz BW, Tilby MJ. 2007. gammaH2AX foci form preferentially in euchromatin after ionising-radiation. PLoS One. 2:e1057.
   PubMed Web of Science ®Google Scholar
• Crea F, Hurt EM, Mathews LA, Cabarcas SM, Sun L, Marquez VE, Danesi R, Farrar WL. 2011. Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer. Mol Cancer. 10:40.
   PubMed Web of Science ®Google Scholar
• Debeb BG, Gong Y, Atkinson RL, Sneige N, Huo L, Gonzalez-Angulo AM, Hung MC, Valero V, Ueno NT, Woodward WA. 2014. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer. J Exp Clin Cancer Res. 33:58.
   PubMed Web of Science ®Google Scholar
• Delgado-Olguín P, Huang Y, Li X, Christodoulou D, Seidman CE, Seidman JG, Tarakhovsky A, Bruneau BG. 2012. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat Genet. 44:343–347.
   PubMed Web of Science ®Google Scholar
• Dellino GI, Schwartz YB, Farkas G, McCabe D, Elgin SC, Pirrotta V. 2004. Polycomb silencing blocks transcription initiation. Mol Cell. 13:887–893.
   PubMed Web of Science ®Google Scholar
• Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4:3.
   PubMed Web of Science ®Google Scholar
• Ezhkova E, Pasolli HA, Parker JS, Stokes N, Su IH, Hannon G, Tarakhovsky A, Fuchs E. 2009. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell. 136:1122–1235.
   PubMed Web of Science ®Google Scholar
• Falk M, Lukásová E, Kozubek S. 2008. Chromatin structure influences the sensitivity of DNA to gamma-radiation. Biochem Biophys Acta. 1783:2398–2414.
   PubMed Web of Science ®Google Scholar
• Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. 2004. H2AX: the histone guardian of the genome. DNA Repair (Amst). 3:959–967.
   PubMed Web of Science ®Google Scholar
• Gross DS, Garrard WT. 1988. Nuclease hypersensitive sites in chromatin. Annu Rev Biochem. 57:159–197.
   PubMed Web of Science ®Google Scholar
• He LR, Liu MZ, Li BK, Jia WH, Zhang Y, Liao YJ, Chen YC, Zhang LJ, Guan XY, Zeng YX, et al. 2010. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Int J Cancer. 127:138–147.
   PubMed Web of Science ®Google Scholar
• Hu S, Yu L, Li Z, Shen Y, Wang J, Cai J, Xiao L, Wang Z. 2010. Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo. Cancer Biol Ther. 10:788–795.
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57.
   PubMed Web of Science ®Google Scholar
• Knops K, Boldt S, Wolkenhauer O, Kriehuber R. 2012. Gene expression in low- and high-dose-irradiated human peripheral blood lymphocytes: possible applications for biodosimetry. Radiat Res. 178:304–312.
   PubMed Web of Science ®Google Scholar
• Kouzarides T. 2007. Chromatin modifications and their function. Cell. 128:693–705.
   PubMed Web of Science ®Google Scholar
• Liu S, Tao Y, Chen X, Cao Y. 2012. The dynamic interplay in chromatin remodeling factors polycomb and trithorax proteins in response to DNA damage. Mol Biol Rep. 39:6179–6185.
   PubMed Web of Science ®Google Scholar
• Lowndes NF, Toh GW. 2005. DNA repair: the importance of phosphorylating histone H2AX. Curr Biol. 15:R99–R102.
   PubMed Web of Science ®Google Scholar
• Lüscher-Firzlaff J, Gawlista I, Vervoorts J, Kapelle K, Braunschweig T, Walsemann G, Rodgarkia-Schamberger C, Schuchlautz H, Dreschers S, Kremmer E, et al. 2008. The human trithorax protein hASH2 functions as an oncoprotein. Cancer Res. 68:749–758.
   PubMed Web of Science ®Google Scholar
• Meng X, Huang Z, Wang R, Jiao Y, Li H, Xu X, Feng R, Zhu K, Jiang S, Yan H, et al. 2014. The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy. Radiat Oncol. 9:188.
   PubMed Web of Science ®Google Scholar
• Miller T, Krogan NJ, Dover J, Erdjument-Bromage H, Tempst P, Johnston M, Greenblatt JF, Shilatifard A. 2001. COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc Natl Acad Sci USA. 98:12902–11297.
   PubMed Web of Science ®Google Scholar
• Orian JM, Vasilopoulos K, Yoshida S, Kaye AH, Chow CW, Gonzales MF. 1992. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br J Cancer. 66:106–112.
   PubMed Web of Science ®Google Scholar
• Orzan F, Pellegatta S, Poliani PL, Pisati F, Caldera V, Menghi F, Kapetis D, Marras C, Schiffer D, Finocchiaro G. 2011. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Neuropathol Appl Neurobiol. 37:381–394.
   PubMed Web of Science ®Google Scholar
• Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 273:5858–5868.
   PubMed Web of Science ®Google Scholar
• Sak A, Stuschke M, Groneberg M, Kübler D, Pöttgen C, Eberhardt WE. 2012. Inhibiting the aurora B kinase potently suppresses repopulation during fractionated irradiation of human lung cancer cell lines. Int J Radiat Oncol Biol Phys. 84:492–509.
   PubMed Web of Science ®Google Scholar
• SAS/STAT User’s Guide. 2009. Version 9.2. SAS Institute; Carry, North Carolina.
   Google Scholar
• Schwartz YB, Pirrotta V. 2007. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet. 8:9–22.
   PubMed Web of Science ®Google Scholar
• Short SC, Martindale C, Bourne S, Brand G, Woodcock M, Johnston P. 2007. DNA repair after irradiation in glioma cells and normal human astrocytes. Neuro-oncology. 9:404–411.
   PubMed Web of Science ®Google Scholar
• Sparmann A, van Lohuizen M. 2006. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer. 6:846–856.
   PubMed Web of Science ®Google Scholar
• Steward MM, Lee JS, O’Donovan A, Wyatt M, Bernstein BE, Shilatifard A. 2006. Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat Struct Mol Biol. 13:852–854.
   PubMed Web of Science ®Google Scholar
• Stuschke M, Sak A, Wurm R, Sinn B, Wolf G, Stüben G, Budach V. 2002. Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint. Int J Radiat Biol. 78:807–819.
   PubMed Web of Science ®Google Scholar
• Suvà ML, Riggi N, Janiszewska M, Radovanovic I, Provero P, Stehle JC, Baumer K, Le Bitoux MA, Marino D, Cironi L, et al. 2009. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 69:9211–9218.
   PubMed Web of Science ®Google Scholar
• Taghian A, Suit H, Pardo F, Gioioso D, Tomkinson K, DuBois W, Gerweck L. 1992. In vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 23:55–62.
   PubMed Web of Science ®Google Scholar
• Tsang DP, Cheng AS. 2011. Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. J Gastroenterol Hepatol. 26:19–27.
   PubMed Web of Science ®Google Scholar
• van Kemenade FJ, Raaphorst FM, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP, Meijer CJ. 2001. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood. 97:3896–3901.
   PubMed Web of Science ®Google Scholar
• Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, et al. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 419:624–629.
   PubMed Web of Science ®Google Scholar
• Wagener N, Holland D, Bulkescher J, Crnković-Mertens I, Hoppe-Seyler K, Zentgraf H, Pritsch M, Buse S, Pfitzenmaier J, Haferkamp A, et al. 2008. The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells. Int J Cancer. 123:1545–1550.
   PubMed Web of Science ®Google Scholar
• Wu Z, Lee ST, Qiao Y, Li Z, Lee PL, Lee YJ, Jiang X, Tan J, Aau M, Lim CZ, et al. 2011. Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage. Cell Death Differentiat. 18:1771–1779.
   PubMed Web of Science ®Google Scholar
• Wu Z, Wang Q, Wang L, Li G, Liu H, Fan F, Li Z, Li Y, Tu Y. 2013. Combined aberrant expression of Bmi1 and EZH2 is predictive of poor prognosis in glioma patients. J Neurol Sci. 335:191–196.
   PubMed Web of Science ®Google Scholar
• Wu ZL, Zheng SS, Li ZM, Qiao YY, Aau MY, Yu Q. 2010. Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ. 17:801–810.
   PubMed Web of Science ®Google Scholar
• Xia H, Zhang W, Li Y, Guo N, Yu C. 2014. EZH2 silencing with RNA interference induces G2/M arrest in human lung cancer cells in vitro. Biomed Res Int. 2014:348728.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen L, Han L, Shi Z, Zhang J, Pu P, Kang C. 2015. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma. Cancer Lett. 356:929–936.
   PubMed Web of Science ®Google Scholar